TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
MED-EL has launched TICI Unico, a cochlear implant designed to work without externally visible hardware during everyday use. The company describes it as the world’s only totally invisible cochlear implant; details about availability, eligibility and clinical performance were not provided in the launch report.
MED-EL has launched TICI Unico, a cochlear implant designed to place its microphone and other components beneath the skin, eliminating the externally visible hardware used with conventional cochlear implants. The Innsbruck, Austria-based company describes it as the world’s only totally invisible cochlear implant; the launch report does not give a date for general availability or explain which patients can receive it.
Unlike conventional cochlear implants, which use an external sound processor worn behind the ear or on the head, TICI Unico is designed to function entirely under the skin. MED-EL says the microphone is implanted too, so the system requires no external hardware during everyday use. The product is the commercial outcome of the company’s TICI development program, which has been followed by the hearing care industry for several years.
The launch follows feasibility study results and early surgeries in Europe involving the TICI platform, according to the report. It does not provide study data, describe the surgical procedure, or state how many people have received the technology. Those omissions mean the announcement establishes the product’s introduction, but offers limited detail for assessing its clinical evidence or practical availability.
MED-EL presents the implant as a possible option for people who want discretion and convenience alongside hearing performance. The company says an implant beneath the skin is not affected by water and describes use while sleeping, showering and swimming as a potential advantage. These are company claims about the intended experience; the launch report does not provide independent testing, performance comparisons or conditions for those activities.
A Shift Away From External Hardware
The launch addresses a long-standing design goal in cochlear implants: restoring hearing without visible equipment worn on the head. If the system works as intended for eligible recipients, it could change daily routines by removing the need to put on, remove and manage an external processor. The company also points to possible use during activities in which external devices can be inconvenient, including sleep and water exposure.
That design may matter to people who value discretion, but invisibility alone does not establish how well the implant performs or whether it will suit a particular person. Hearing outcomes, candidacy, surgical risks, maintenance and access remain central considerations. The report gives no comparative results or pricing, so readers cannot yet weigh those factors against the benefits MED-EL describes.
From TICI Research to Launch
Fully implantable hearing devices have been an area of interest across the hearing implant industry, with manufacturers exploring ways to reduce or remove external components. MED-EL’s TICI program has moved through feasibility work and early operations in Europe before this product launch. The report calls TICI Unico the first-to-market totally implantable cochlear implant, while MED-EL calls it the world’s only totally invisible one; both descriptions should be understood as claims reported in the launch coverage.
MED-EL is a privately held company headquartered in Innsbruck. It develops cochlear, middle ear, bone conduction and auditory brainstem implants. The report also notes other recent company activity, including acquiring two gene therapy programs from Rescue Hearing and a collaboration with Starkey on bimodal Bluetooth connectivity. Those developments provide company context but do not establish details about TICI Unico’s performance or availability.
““TICI Unico is a new category of an implant. It is totally new and it is the realization of a dream that I have had for a very long time.””
— Ingeborg Hochmair, MED-EL co-founder and CEO
Availability and Evidence Still Unclear
The launch report does not specify when or where TICI Unico will be available, how much it will cost, or which patients meet the criteria for implantation. It also does not detail the operation, device upkeep, battery or charging arrangements, or how the implant handles sound processing over time.
Although the report refers to feasibility results and early surgeries in Europe, it supplies no study size, follow-up period, outcome measures or complication data. The evidence available in the report is therefore insufficient to compare TICI Unico’s hearing performance with conventional cochlear implants or to determine how broadly its water and around-the-clock use claims apply.
Details Needed for Patient Decisions
Further information from MED-EL could clarify regulatory status, launch markets, patient eligibility and the evidence from feasibility work and early procedures. Prospective recipients and clinicians will also need product-specific information about surgery, follow-up care, maintenance and hearing outcomes. Until those details are published, the announcement confirms a new product launch and its fully implanted design, while the timeline and practical access remain unspecified.
Key Questions
What is MED-EL TICI Unico?
It is a cochlear implant designed to place its microphone and other components beneath the skin, without externally visible hardware during everyday use, according to MED-EL.
How does it differ from a conventional cochlear implant?
Conventional cochlear implants use an external sound processor worn behind the ear or on the head. TICI Unico is designed to operate with its components, including the microphone, implanted beneath the skin.
Can recipients use it while swimming or sleeping?
MED-EL says the implant is not affected by water because it is under the skin and describes use during sleep, showering and swimming. The launch report does not give independent test results or activity-specific guidance.
When will TICI Unico be available, and who can receive it?
The launch report does not state an availability date, rollout markets, price or patient eligibility criteria. Those details remain to be announced or confirmed.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
